

Stealth Biotherapeutics Corp, a clinical-stage biotechnology company focused on the mitochondrial dysfunction, has raised $20 million in a private placement. The investor was Morningside.
Source: Press Release
Stealth Biotherapeutics Corp, a clinical-stage biotechnology company focused on the mitochondrial dysfunction, has raised $20 million in a private placement.
Stealth Biotherapeutics Corp, a clinical-stage biotechnology company focused on the mitochondrial dysfunction, has raised $20 million in a private placement. The investor was Morningside.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination